Sentences with phrase «statins in»

Considering the cost - effectiveness of statins in family practice in Turkey from a payer perspective
Because many of the proteins that are lipid - modified cause cancer, there are now hopes that it will be possible to use statins in the treatment of cancer.
Threats, opportunities, and statins in the modern management of heart failure.
Prof Noakes is absolutely correct in raising this issue because we NEED cholesterol but most people don't need statins in order to correct any imbalance.
«It is possible that older adults may not be able to distinguish between muscle pain related to a statin effect or an effect of aging and therefore adverse effects of statins in older adults may be under - reported.»
Since there have never been any reports of the kinds of side effects associated with prescription statins in users of red yeast rice, I would say that doesn't make any difference.
«Doctors give statins in one of two ways,» Abramson explains.
She added: «Some doctors have been hesitant to prescribe statins in patients with very low LDL - C because of uncertain benefit and the risk of side effects with statins.
Children with inherited high levels of cholesterol who receive cholesterol - lowering statins in their early years have a lower risk of coronary heart disease than their affected parents, according to research presented at the American Heart Association's Scientific Sessions 2013.
Those studies, however, failed to account for cholesterol levels prior to the widespread use of statins in the U.S. population, Huang said, noting that as a strength of the new study.
At its national meeting in November 2013, the American Heart Association, in collaboration with the American College of Cardiology, presented and published its new guidelines for the use of statins in the treatment and primary prevention of heart attacks and strokes, in which the organizations also recommended wider utilization in both treatment and prevention.
The Mayo task force does not recommend in favor of or against the use of statins in patients with diabetes in whom the risk for heart attacks or stroke is low based on the calculator proposed by the ACC / AHA.
The small study, based on a survey of 236 cardiologists and internal medicine physicians and trainees at a large tertiary academic medical center, found that although physicians rate nutrition to be as important as statins in terms of reducing the risk of cardiovascular disease, only 13.5 percent agreed or strongly agreed that they were adequately trained to discuss nutrition with patients.
The data do not demonstrate a therapeutic benefit from statins in patients with moderate to severe COPD.
«Identifying the factors underlying decreased use of statins in women who should be treated is a first step toward overcoming these barriers and improving cardiovascular outcomes for women.»
«I think that our findings provide compelling evidence for a trial of statins in FA patients to potentially reduce their cardiovascular risk,» Blair said.
REDUCE - IT is the first multinational cardiovascular outcomes study evaluating the effect of prescription pure EPA therapy, or any triglyceride - lowering therapy, as an add - on to statins in patients with high cardiovascular risk who, despite stable statin therapy, have elevated triglyceride levels (150 - 499 mg / dL).
Patients who were treated with a statin in the hospital after suffering from a hemorrhagic stroke were significantly more likely to survive than those who were not, according to a study published today in JAMA Neurology.

Not exact matches

Lipitor was the only cholesterol - reducing statin to make the list, though statins are among the most popular and best - selling in the US.
High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real - world analysis of statin - treated patients with high cardiovascular risk and well - controlled low - density lipoprotein cholesterol [abstract].
Eric Topol speaks with Sekar Kathiresan about cardiovascular genomics, why «DNA isn't destiny,» and why we still have heart attacks in spite of statins.
Topline results for bempedoic acid in combination with a high dose statin, expected in September, and outcomes results for PCSK9 and CETP inhibitors, likely in 1H17, are the most notable catalysts over the next 12 months.
I just replaced «statins» by «oral contraceptives» in your sentence.
So if statin cholesterol - lowering drugs are part of the problem in causing Alzheimer's Disease, can we really expect that pharmaceutical companies will be able to develop drugs to cure Alzheimer's?
In 2011, Dr. Stephanie Seneff published research looking at the effects of a low - fat diet and statin drugs in relation to Alzheimer's DiseasIn 2011, Dr. Stephanie Seneff published research looking at the effects of a low - fat diet and statin drugs in relation to Alzheimer's Diseasin relation to Alzheimer's Disease.
However, the main reason the lipid theory of heart disease continues in the U.S. is because to admit that this hypothesis is wrong is to admit that a whole class of pharmaceutical drugs is unnecessary, statin drugs that lower one's cholesterol artificially.
A 2005 study in the American Journal of Clinical Nutrition found that consuming almonds as part of a heart - healthy diet can be just as effective at lowering LDL «bad» cholesterol levels as first generation statin drugs.
You might have also noticed that Statin Drugs have come under a negative light in some studies.
But the researchers wanted to know if the drug, when combined with statin treatment, could also reduce the risk of heart disease in people with type 2 diabetes.
A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of «good» cholesterol, despite being treated with statins.
The findings suggest that fenofibrate therapy may be beneficial in the way the researchers hoped: by reducing cardiovascular events in patients with type 2 diabetes who take statins but still have especially high triglycerides levels and low HDL cholesterol levels.
Joseph L. Witztum, an endocrinologist at the University of California, San Diego, argues that people should be treated with statins early in life to achieve and maintain LDL cholesterol levels below 50 mg / dL.
An estimated 20 million Americans take statins, making these cholesterol - lowering drugs the most widely prescribed class in the world.
In 2007 Karas published a study in the Journal of the American College of Cardiology suggesting that the risk of complications increases with statin dosIn 2007 Karas published a study in the Journal of the American College of Cardiology suggesting that the risk of complications increases with statin dosin the Journal of the American College of Cardiology suggesting that the risk of complications increases with statin dose.
The current NCEP guidelines, published in 2001 and revised in 2004, recommend statins for heart disease patients with LDL («bad») cholesterol levels greater than 70 milligrams per deciliter of blood and for people who have a moderately elevated risk of heart disease as well as LDL levels above 100 mg / dL.
Direct evidence for the benefits of statins as primary prevention — that is, for preventing heart attacks in people who do not yet have heart disease — comes largely from one clinical trial published in 2008 in the New England Journal of Medicine.
When patients were unaware they were taking statins there was no reported increase in muscle - related symptoms.
«A different statin may be well tolerated in patients who were unable to tolerate a particular statin
Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the U.S. Preventive Services Task Force.
Studies following the scandal suggested that statins might impede protection from oxidative stress or alter other chemical reactions in muscle cells.
Sleep disturbance was lower in the statins group compared to placebo (1.00 % vs 1.46 %) and there was an increase in renal and urinary side effects in the statins group compared to placebo (1.87 % vs 1.51 %), both of which require further investigation.
In that calculation, the number of people who would avoid a cardiovascular event is not 5 percent, as the review in Lancet estimated, but somewhere between 1 and 2 percent — which means only 100 or at most 200 of every 10,000 healthy people taking a statin would benefiIn that calculation, the number of people who would avoid a cardiovascular event is not 5 percent, as the review in Lancet estimated, but somewhere between 1 and 2 percent — which means only 100 or at most 200 of every 10,000 healthy people taking a statin would benefiin Lancet estimated, but somewhere between 1 and 2 percent — which means only 100 or at most 200 of every 10,000 healthy people taking a statin would benefit.
The trial included 501 patients with atherosclerotic cardiovascular disease (ASCVD) and elevated LDL cholesterol (> 70mg / ml) despite maximum tolerated statin therapy and patients without ASCVD but with high cardiovascular risk conditions such as diabetes and familial hypercholesterolaemia in whom LDL cholesterol was > 100mg / dl despite maximally tolerated statin therapy.
Research has shown women have poorer adherence to taking their statin medication to treat high cholesterol, perhaps due to somewhat dissimilar pharmacological properties in a woman's body than a man's.
In one routine - care study, reported in 2013 in Annals of Internal Medicine, 8 percent of patients stopped taking statins because of side effectIn one routine - care study, reported in 2013 in Annals of Internal Medicine, 8 percent of patients stopped taking statins because of side effectin 2013 in Annals of Internal Medicine, 8 percent of patients stopped taking statins because of side effectin Annals of Internal Medicine, 8 percent of patients stopped taking statins because of side effects.
The next step of the research, conducted in collaboration with David Lynch, MD, PhD, a professor of Neurology at Children's Hospital of Philadelphia (CHOP), showed that statins may be able to help Friedreich's ataxia patients increase their naturally low ApoA - I levels and so increase their HDL levels, which might help prevent heart disease.
Additionally, newer and better drugs such as anticoagulants, statins and antihypertensives are now routinely used in heart disease.
Statins are HMGR inhibitors with inhibition constant values in the nanomolar range that effectively lower serum cholesterol levels and are widely prescribed in the treatment of hypercholesterolemia.
Trends in Statin Therapy among Adults (Age ≥ 18), United States, 2000 to 2011.
One early statin called Baycol was withdrawn from the market in 2001 after it was linked to 52 deaths from a breakdown of muscle tissue.
a b c d e f g h i j k l m n o p q r s t u v w x y z